NCT04413877 Implementation of the Integrated Care of Older People App and ICOPE Monitor in Primary Care (ICOPE) Status WITHDRAWN Phase N/A
NCT04412772 Trial of Tocilizumab for Treatment of Severe COVID-19: ARCHITECTS Status TERMINATED Phase PHASE3
NCT04412538 Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 Status COMPLETED Phase PHASE1/PHASE2
NCT04412395 Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease Status UNKNOWN Phase PHASE2
NCT04412330 Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19 Status COMPLETED Phase NA
NCT04412304 Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients Status COMPLETED Phase N/A
NCT04412291 A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study Status UNKNOWN Phase PHASE2
NCT04412252 Safety and Efficacy of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia Who Are Receiving Standard of Care Therapy Status WITHDRAWN Phase PHASE2
NCT04412226 Effect of Using Barrier Devices for Intubation in COVID-19 Patients Status COMPLETED Phase N/A
NCT04412018 An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19 Status COMPLETED Phase PHASE2
NCT04411628 A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19 Status COMPLETED Phase PHASE1